Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Alzheimer's Disease

Methodology

Alzheimer’s disease is brain disorder that causes severe dementia. It is mainly found in older people, appearing after age 60. According to the National Institutes of Health, approximately three percent of people aged 65-74 have Alzheimer’s disease. Special Topics has analyzed the literature published on this disease in the past decade. There are four main themes manifested in the top 20 papers from this time period. The first is most prevalent: intensive research into the structure and function of the various alleles of apolipoprotein-E, particularly the type 4 allele and its role in the pathogenesis of Alzheimer’s disease. Closely linked to apolipoprotein-E research is that on the amyloid peptides. The beta-amyloid peptide, which has been found in cerebrospinal fluid and other human biological fluids, has the potential to be used as a diagnostic test as well as a therapeutic strategy. Several cloning and genetic linkage studies are in the top 20 list as well, examining the potential susceptibility of specific gene loci for missense mutations which might result in Alzheimer’s disease. Clinical trials of high-dose tacrine, selegene, and alpha-tocopherol report promising results for slowing the progression of the disease and improving the quality of life in affected patients. One paper on the list discusses the potential role of estrogen in postmenopausal women for delaying onset of Alzheimer’s disease.

Methodology

To construct this database, papers were extracted based on a title word search and the supplied keywords for Alzheimer's Disease. The keywords used were as follows: Alzheimer*.

The baseline time span for this database is 1992-2002. The resulting database contained 19,057 papers; 29,502 authors; 79 countries; 1,296 journals; and 5,875 institutions.

Rankings

Once the database was in place, it was used to generate the lists of top 20 papers, authors, journals, institutions, and nations, covering a time span of 1992-2002.

The top 20 papers are ranked according to total cites. Rankings for author, journal, institution, and country are listed in three ways: according to total cites, total papers, and total cites/paper. The paper thresholds used to determine scientist, institution, country, and journal rankings according to total cites/paper were as follows: 29, 27, 35, and 44, respectively.

Return to previous page

Alzheimer's Disease Menu || All Topics Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.